Preeclampsia (PE) is characterised by the new onset of hypertension after the 20th week of
pregnancy, with or without proteinuria or hypertension that leads to end-organ dysfunction …

Background: Hypertensive disorders of pregnancy (HDP) is a disease associated with
elevated blood pressure during pregnancy, accounting for 5–10% of all pregnancies, which …

Antecedentes: La preeclampsia es un trastorno multiorgánico asociado con la morbi-
mortalidad materna y perinatal. En el Perú, su incidencia es del 10% y causa el 22% de las …

Background: Preeclampsia is a multiorgan disorder associated with maternal and perinatal
morbi-mortality. In Peru, incidence is 10% and accounts for 22% of maternal deaths …

ABSTRACT Background: Preeclampsia (PE), is a pregnancy-specific complication with the
placental origin which associated with altered expression of angiogenic factors. Vascular …

Aim Vascular endothelial growth factor (VEGF) is an angiogenic factor whose production is
increased in pre‐eclampsia (PE). Therefore, the present study was conducted aiming at …

Objectives: The aim of this study was to assess the genetic association between vascular
endothelial growth factor (VEGF) gene polymorphisms and the risk of pre-eclampsia (PE) …

Objective To determine the impact of damaging genetic variation in proangiogenic pathways
on placental function, complications of pregnancy, fetal growth, and clinical outcomes in …

Аннотация Обзор посвящен одной из актуальных проблем современного акушерства-
фетоплацентарной недостаточности. В статье обобщены данные литературных …

Background Preeclampsia can lead to adverse maternal and perinatal outcomes. There are
few studies on the genetic factors associated with preeclampsia in Africa in general and in …